Preemptive Treatment With Elbasvir and Grazoprevir for Hepatitis C–Viremic Donor to Uninfected Recipient Kidney Transplantation

INTRODUCTION: Long wait times for kidney transplants have prompted investigation into strategies to decrease the discarding of potentially viable organs. Recent reports suggest that kidneys from hepatitis C virus (HCV)−infected donors may be transplanted into HCV-naive donors followed by direct-acti...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Kidney Int Rep
Главные авторы: Sise, Meghan E., Strohbehn, Ian A., Chute, Donald F., Gustafson, Jenna, Van Deerlin, Vivianna M., Smith, Jennifer R., Gentile, Caren, Wojciechowski, David, Williams, Winfred W., Elias, Nahel, Chung, Raymond T.
Формат: Artigo
Язык:Inglês
Опубликовано: Elsevier 2020
Предметы:
Clinical Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7136432/
https://ncbi.nlm.nih.gov/pubmed/32280841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2020.01.001
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы